Our latest research, company updates and industry insight
The ClearSky Medical Diagnostics team attended an event in Leeds in November celebrating collaboration and innovation in developing new medical technologies across the region.
ClearSky Medical Diagnostics will be heading to Hong Kong in October for the 22nd International Congress of Parkinson’s Disease and Movement Disorders (MDS).
ClearSky’s PD-Monitor can be used to confirm the diagnosis of Parkinson’s in very early stages based on the presence of bradykinesia in the dominant affected side, according to a groundbreaking study in China.
ClearSky Medical Diagnostics is proud to be part of an award-winning team that scooped top prize in the Human-Competitive Awards (Humies) 2018 in Japan.
Members of the ClearSky team are finalists in the Human-Competitive Awards at the 2018 Genetic & Evolutionary Computation Conference (GECCO) in Japan.
ClearSky’s PD-Monitor has been used in a nationwide study to investigate whether statins are effective in slowing the progress of Parkinson’s.
ClearSky’s co-founder and director Professor Stephen Smith was recently awarded a secondment to evaluate the technology for measuring the symptoms of Parkinson’s. Professor Stephen Smith, Deputy Head of the Department of Electronic Engineering at the University of...
ClearSky Medical Diagnostics is delighted to announce the appointment of two new members of staff – Dr Marta Vallejo and Dr Amir Dehsarvi.
Implementing ClearSky’s LID-Monitor in UK hospitals ‘has the potential to reduce costs to the NHS and increase the quality of life of people with Parkinson’s’…
Levodopa is the most effective and commonly used drug for treating Parkinson’s. It is a chemical building-block that your body converts into dopamine. People with Parkinson’s lack enough dopamine because some of the brain cells that make it have died. The loss of...
The ClearSky China team exhibited at the 2018 Shanghai Ruijin International Forum of Translational Research in Neurodegenerative Disease in March. It was also the second annual meeting of neurodegenerative diseases of The Chinese Neuroscience Society. Around 300...
Evolutionary algorithms are inspired by the biological model of evolution and natural selection proposed by Darwin. We have used evolutionary algorithms to recognise movement characteristics of Parkinson’s.